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Tuberculosis remains one of the main fatal infections in humans. With
annual morbidity and mortality rates worldwide of 8 and 2 million cases
respectively, the disease is far from being eradicated. In fact, the dangerous
liaison between TB and HIV, and the increasing incidences of multi-drug
resistant strains of Mycobacterium tuberculosis are aggravating the
problem. The latest epidemiological data indicate that new drugs and a
novel vaccine are urgently needed to control TB adequately.
This volume summarizes the state of the art in the prevention, diagnosis
and therapy of TB. In addition, the molecular biology of M. tuberculosis
and the immunology of the host response are presented. Researchers are
beginning to understand how the immune response controls the pathogen
quite efficiently, yet fails to eradicate it completely in the 2 billion people
worldwide who are infected but do not develop the disease. Finally, recent
strategies towards the development of new vaccines are reviewed.
Scientists investigating the epidemiology, immunology and molecular
biology of TB or engaged in vaccine and drug development as well as
physicians and social workers treating TB patients will benefit from this
timely overview.
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The book series “Issues in Infectious Diseases” (formerly:
Infectiology): Infections are a constant threat to human health. Over the
last two decades a number of new infective agents such as HIV and
prions have been identified, and several infectious diseases previously
considered under control have suddenly reemerged. The problem of
infection is aggravated by the resistance of many microorganisms to
currently available antiinfectives and by the growing number of immuno-
compromised people worldwide. The steadily rising incidence of
nosocomial infections is a further cause for concern.
This series presents original data and reviews the latest clinical
information on infectious diseases of bacterial, viral, fungal and parasitic
origin. Covering epidemiology, pathogenesis, prevention and treatment,
it also considers the latest diagnostic techniques, evaluates new
antimicrobial drugs and reports recent advances in vaccine development.
As infections involve almost all branches of medicine, books published
in this series will represent a valuable source of information for a wide
spectrum of clinicians and health care professionals.
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